Delivery Order SPE2DB20D2002-SPE2DB24FL28S
- Not listed
- This federal contract award, valued at $1,127.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Cetirizine HCL 5 mg tablets in 100-count bottles, with a completion date of May 6, 2024. This contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued up to $999,999,999.00 and expiring in November 2026. The IDC serves as the...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,862.07 firm-fixed-price delivery order is for the supply of 4,564,253,153 units of Cetirizine 5mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as a primary vehicle...
- This federal contract award, with ID SPE2DB20D2104|SPE2DB24FS31P, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $2,407.16 firm fixed-price delivery order is for the supply of 4,563,489,694 units of Cetirizine HCL 10 MG Tablets, a pharmaceutical product. This award is not associated with a set-aside program. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00...
- This federal contract award, valued at $2,197.91, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of cetirizine hydrochloride 1 mg/mL solution in 120 mL bottles. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at up to $999,999,999.00 and runs through November 2026. This IDC...
- This federal contract award was issued by the U.S. Department of Defense (DoD) Medical Supply Chain agency to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The $1,907.82 fixed-price delivery order is for the supply of 4,564,368,164 units of the pharmaceutical drug Cetirizine Hydrochloride 5 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the Defense Logistics Agency (DLA) Troop Support Medical, valued at...
- This federal contract award, with a ceiling value of $3,543.80, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order (SPE2DB22D1103|SPE2DB24FTCM7) for the supply of 4,563,043,076 units of Cetirizine HCL 5 mg tablets, a generic pharmaceutical product. The contract has an ultimate completion date of December 11, 2023 and uses a firm fixed price pricing type. This...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $63,512.75, is for the delivery of 4,563,866,824 units of the drug Cetirizine HCL 5 mg tablets in 100-count bottles. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The Delivery Order contract, valued at $1,188.32, is for the supply of Cetirizine HCL 5 mg Tablets in 100-count packages. The contract has an ultimate completion date of October 17, 2023, and is a Firm Fixed Price type. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which is a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,108.38 firm fixed-price delivery order is for the supply of 4,562,252 units of Cetirizine HCL 10 mg tablets. The award has a completion date of September 21, 2023 and was made under the company's $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as a primary vehicle for...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Cetirizine Hydrochloride 5 mg tablets. The contract has a ceiling value of $1,672.40 and an ultimate completion date of April 26, 2024. This contract is not designated as a set-aside award. Amerisourcebergen Drug Corp has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB24FL28SDelivery Order
This federal contract award, valued at $2,421.43, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide 4,563,803,656 units of Cetirizine HCL 5 mg tablets. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November 2026. This IDC enables Cencora, Inc. to efficiently deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition. Cencora, Inc. also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 2/28/24 |